Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention

Atherosclerosis

Volumn 209, Issue 2, 2010, Pages 403-414

  Balestrieri, Maria Luisa ^a   Lu, Shi Jiang ^b,c   de Nigris, Filomena ^a   Giovane, Alfonso ^a   Williams Ignarro, Sharon ^d   D'Armiento, Francesco Paolo ^e   Feng, Qiang ^b,c   Fiorito, Carmela ^f   Testa, Gianluca ^e,g,h   Pastore, Lucio ^e,g,i   Cacciatore, Francesco ^j   Mancini, Francesco Paolo ^k   Servillo, Luigi ^a   De Rosa, Gaetano ^e   Pagliarulo, Caterina ^k   Rienzo, Monica ^a   Minucci, Pellegrino Biagio ^a   Farzati, Bartolomeo ^a   Salvatore, Francesco ^e,g,i   Rengo, Franco ^e,j   Ignarro, Louis Joseph ^d   Giordano, Antonio ^l,m   Baker, Andrew ⁿ   Lanza, Robert ^b,c   Napoli, Claudio ^a,e,f   more..

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Advanced Cell Technology   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f IRCCS MULTIMEDICA   (Italy)

^g CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^h UNIVERSITY OF MOLISE   (Italy)

ⁱ European School of Molecular Medicine SEMM   (Italy)

^j IRCCS   (Italy)

^k UNIVERSITY OF SANNIO   (Italy)

^l Temple University   (United States)

^m UNIVERSITY OF SIENA   (Italy)

ⁿ UNIVERSITY OF GLASGOW   (United Kingdom)

more..

Author keywords

Antioxidants; Bone marrow cell; Diabetes; Hemangioblasts; Ischemic hindlimb; L Arginine; Nitric oxide; Peripheral arterial disease

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN E; ARGININE; ASCORBIC ACID; CD31 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; NITRIC OXIDE; TELOMERASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD CELL; CAPILLARY DENSITY; CELL FUNCTION; CELL INFILTRATION; CONTROLLED STUDY; DIABETES MELLITUS; EMBRYO; ENZYME ACTIVITY; HEMATOPOIETIC STEM CELL; HINDLIMB; LIMB BLOOD FLOW; LIMB ISCHEMIA; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SENESCENCE;

ANIMALS; APOLIPOPROTEINS E; ARGININE; ASCORBIC ACID; BONE MARROW TRANSPLANTATION; DIABETES MELLITUS, EXPERIMENTAL; HEMANGIOBLASTS; HINDLIMB; ISCHEMIA; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL VASCULAR DISEASES; REGIONAL BLOOD FLOW; VITAMIN E;

EID: 77950020068     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.10.022     Document Type: Article

References (58)

1. Mohler E.R. Therapy insight: peripheral arterial disease and diabetes-from pathogenesis to treatment guidelines. Nat Clin Pract Cardiovasc Med 2007, 4:151-162.
2. Muhs B.E., Gagne P., Sheehan P. Peripheral arterial disease: clinical assessment and indications for revascularization in the patient with diabetes. Curr Diab Rep 2005, 5:24-29.
3. Yla-Herttuala S., Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003, 9:694-701.
4. Rajagopalan S., Olin J., Deitcher S., et al. Use of a constitutively active hypoxia-inducible factor-1α transgene as a therapeutic strategy in no-option critical limb ischemia patients. Phase I dose-escalation experience. Circulation 2007, 115:1234-1243.
5. Lu S.J., Feng Q., Caballero S., et al. Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods 2007, 4:501-509.
6. Chung Y., Klimanskaya I., Becker S., et al. Human embryonic stem cell lines generated without embryo destruction. Cell Stem Cell 2008, 2:113-117.
7. Napoli C., Maione C., Schiano C., et al. Oxidation-specific mechanisms and cardiovascular repair induced by autologous bone marrow cell infusion. Trends Mol Med 2007, 13:278-286.
8. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712.
9. Hamano K., Li T.S., Kobayashi T., et al. The induction of angiogenesis by the implantation of autologous bone marrow cells: a novel and simple therapeutic method. Surgery 2001, 130:44-54.
10. Hirata K., Li T.S., Nishida M., et al. Autologous bone marrow cell implantation as therapeutic angiogenesis for ischemic hindlimb in diabetic rat model. Am J Physiol Heart Circ Physiol 2003, 284:H66-70.
11. Tamarat R., Silvestre J.S., Le Ricousse-Roussanne S., et al. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Pathol 2004, 164:457-466.
12. Urbán V.S., Kiss J., Kovács J., et al. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 2007, 26:244-253.
13. Napoli C., Williams-Ignarro S., Byrns R., et al. Therapeutic targeting of stem cell niche in experimental hindlimb ischemia. Nat Clin Pract Cardiovasc Med 2008, 5:571-579.
14. Shintani S., Murohara T., Ikeda H., et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001, 103:897-903.
15. Iwase T., Nagaya N., Fujii T., et al. Adrenomedullin enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia. Circulation 2005, 111:356-362.
16. Miranville A., Heeschen C., Sengenès C., et al. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 2004, 110:349-355.
17. Napoli C., Williams-Ignarro S., de Nigris F., et al. Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb. Proc Natl Acad Sci USA 2005, 102:17202-17206.
18. Tateishi-Yuyama E., Matsubara H., Murohara T., et al. Therapeutic angiogenesis using cell transplantation (TACT) Study investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002, 360:427-435.
19. Higashi Y., Kimura M., Hara K., et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 2004, 109:1215-1218.
20. Bartsch T., Brehm M., Zeus T., et al. Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study). Clin Res Cardiol 2007, 96:891-899.
21. Napoli C., Farzati B., Sica V., et al. Beneficial effects of autologous bone marrow cell infusion and antioxidants/l-arginine in patients with chronic critical limb ischemia. Eur J Cardiovasc Rehabil 2008, 15:709-718.
22. Becker L.B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004, 61:461-470.
23. de Nigris F., Lerman A., Ignarro L.J., et al. Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. Trends Mol Med 2003, 9:351-359.
24. de Nigris F., Lerman L.O., Ignarro S.W., et al. Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress. Proc Natl Acad Sci USA 2003, 100:1420-1425.
25. Tritto I., Ambrosio G. Spotlight on microcirculation: an update. Cardiovasc Res 1999, 42:600-606.
26. Napoli C., Lerman L.O., de Nigris F., Loscalzo J., Ignarro L.J. Glycoxidized low-density lipoprotein downregulates endothelial nitric oxide synthase in human coronary cells. J Am Coll Cardiol 2002, 40:1515-1522.
27. Wautier J.L., Schmidt A.M. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 2004, 95:233-238.
28. Ignarro L.J., Napoli C. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr Diab Rep 2005, 5:17-23.
29. Napoli C., Sica V., Pignalosa O., de Nigris F. New trends in anti-atherosclerotic agents. Curr Med Chem 2005, 12:1755-1772.
30. Cooke J.P., Oka R.K. Atherogenesis and the arginine hypothesis. Curr Atheroscler Rep 2001, 3:252-259.
31. Napoli C., Williams-Ignarro S., de Nigris F., et al. Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc Natl Acad Sci USA 2004, 101:8797-8802.
32. Sheetz M.J., King G.L. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002, 288:2579-2588.
33. Spinetti G., Kraenkel N., Emanueli C., et al. Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. Cardiovasc Res 2008, 78:265-273.
34. Fadini G.P., Miorin M., Facco M., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005, 45:1449-1457.
35. Loomans C.J., de Koning E.J., Staal F.J., et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004, 53:195-199.
36. Sorrentino S.A., Bahlmann F.H., Besler C., et al. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 2007, 116:163-173.
37. Guarante L. Sirtuins as potential targets for metabolic syndrome. Nature 2006, 444:868-874.
38. Ota H., Akishita M., Eto M., et al. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol 2007, 43:571-579.
39. Mattagajasingh I., Kim C.S., Naqvi A., et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA 2007, 104:14855-14860.
40. Potente M., Ghaeni L., Baldessari D., et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev 2007, 21:2644-2658.
41. Balestrieri M.L., Rienzo M., Felice F., et al. High glucose downregulates endothelial progenitor cell number via SIRT1. Biochim Biophys Acta 2008, 1784:936-945.
42. de Nigris F., Williams-Ignarro S., Sica V., et al. Therapeutical effects of concurrent autologous bone marrow cell infusion and metabolic intervention in ischemia-induced angiogenesis in the hypercholesterolemic mouse hindlimb. Int J Cardiol 2007, 117:238-243.
43. Sica V., Williams-Ignarro S., de Nigris F., et al. Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb. Cell Cycle 2006, 5:2903-2908.
44. Baker A.H., Sica V., Work L.M., et al. Brain protection using autologous bone marrow cell, metalloproteinase inhibitors and metabolic treatment in cerebral ischemia. Proc Natl Acad Sci USA 2007, 104:3597-3602.
45. de Nigris F., Balestrieri M.L., Williams-Ignarro S., et al. Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways. J Cardiovasc Pharmacol 2007, 50:424-433.
46. Wang M.C., Bohmann D., Jasper H. JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell 2005, 121:115-125.
47. Fiorito C., Balestrieri M.L., Crimi E., et al. Effect of l-arginine on circulating endothelial progenitor cells after moderate physical training in mice. Int J Cardiol 2008, 126:421-423.
48. Klimanskaya I., Chung Y., Becker S., Lu S.-J., Lanza R. Human embryonic stem-cell lines derived from single blastomeres. Nature 2006, 444:481-485.
49. Salvatore P., Casamassimi A., Sommmese L., et al. Detrimental effects of Bartonella henselae are counteracted by l-arginine and nitric oxide in human endothelial progenitor cells. Proc Natl Acad Sci USA 2008, 105:9427-9432.
50. Emanueli C., Graiani G., Salis M.B., Gadau S., Desortes E., Madeddu P. Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice. Diabetes 2004, 53:1096-1103.
51. Seeger F.H., Haendeler J., Walter D.H., et al. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 2005, 111:1184-1191.
52. de Nigris F., Lerman L.O., Napoli C. New insights in the transcriptional activity and coregulator molecules in the arterial wall. Int J Cardiol 2002, 86:153-168.
53. Arras M., Ito W.D., Scholz D., et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1997, 101:40-50.
54. Bosch-Marce M., Pola R., Wecker A.B., et al. Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemia. Vasc Med 2005, 10:15-22.
55. Callaghan M.J., Ceradini D.J., Gurtner G.C. Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function. Antioxid Redox Signal 2005, 7:1476-1482.
56. Tamarat R., Silvestre J.S., Huijberts M., et al. Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Proc Natl Acad Sci USA 2003, 100:8555-8560.
57. Napoli C., Ignarro L.J. Nitric oxide-releasing drugs. Annu Rev Pharmacol Toxicol 2003, 43:97-123.
58. Balestrieri M.L., Napoli C. Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors. Eur J Cancer 2007, 43:1242-1250.